Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Transaminases increased? 103 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Transaminases increased have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.2% of all adverse event reports for MEPOLIZUMAB.

103
Reports of Transaminases increased with MEPOLIZUMAB
0.2%
of all MEPOLIZUMAB reports
13
Deaths
102
Hospitalizations

How Dangerous Is Transaminases increased From MEPOLIZUMAB?

Of the 103 reports, 13 (12.6%) resulted in death, 102 (99.0%) required hospitalization, and 17 (16.5%) were considered life-threatening.

Is Transaminases increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 103 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Transaminases increased?

METHOTREXATE (1,236) ACETAMINOPHEN (929) ATORVASTATIN (472) RITUXIMAB (448) CYCLOPHOSPHAMIDE (401) PREDNISONE (362) ADALIMUMAB (340) PACLITAXEL (333) ROSUVASTATIN (324) CARBOPLATIN (319)

Which MEPOLIZUMAB Alternatives Have Lower Transaminases increased Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Transaminases increased Reports All Drugs Causing Transaminases increased MEPOLIZUMAB Demographics